MGI Tech debuts high-throughput T7+ sequencer at analytica 2026
Experience live demonstrations of the T7+ and PrepALL, and learn more about MGI’s full sequencing and automation portfolio in Hall A3, Booth 317
26 Mar 2026
MGI Tech at analytica 2026
MGI Tech Co., Ltd. (MGI) is showcasing cutting-edge automation and sequencing technologies at analytica 2026 in Munich, Germany. Making its first appearance at the trade fair, MGI is featuring advanced sequencing and automation platforms, including the new high-throughput sequencer T7+ and the automation workstation PrepALL, designed to revolutionize liquid handling in laboratories around Europe.
Bringing high-throughput sequencing to European labs
MGI introduced the T7+ in September 2025 during the Future of Omics conference in Shenzhen, China. This high-throughput sequencing platform is now available to customers in Europe and Africa, enabling users to process up to 112 WGS or 80 Single cell RNA-seq or 1,920 RNA-seq samples in one run.
MGI’s T7+ sequencing platform is fully agnostic and designed to reduce hands-on time through integrated workflow automation, while allowing users to retain their existing pipelines, tools, and data strategy.
Intelligent automation for labs of all sizes
In addition, the company is exhibiting its automation platform PrepALL, which was first presented during the SLAS in Hamburg in 2025 and is now commercially available globally. The intelligent liquid handler combines key features from other MGI automation platforms in a compact design, enabling the smallest laboratories to adapt automation for their pipetting workflow.
“It is our first time exhibiting during analytica, and I am thrilled to present our latest innovations to the broader European community,” said Fang Chen, General Manager of Europe & Africa at MGI. “We’re invigorated by the diverse audience from different segments gathered here to improve their laboratory workflow solutions. Our robust sequencing technology and sophisticated automation technology are just the start, and we intend to use this trade fair in the future to provide researchers and clinical laboratories with a breadth of equipment.”